Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma
Authors:
Open Access
Abstract
BACKGROUND: PTEN is a candidate tumor‐suppressor gene in a variety of malignant tumors. The prognostic importance of PTEN product protein (PTEN) and its correlation with clinicopathologic characteristics have yet to be delineated in patients with esophageal carcinoma.METHODS: Specimens from 97 patients with esophageal squamous cell carcinoma were used for the immunohistochemical evaluation of PTEN expression.RESULTS: PTEN expression was detected in the nucleus in 48 specimens (49.5%). There were statistically significant correlations between nuclear PTEN expression and macroscopic tumor classification, T stage, and American Joint Committee on Cancer (AJCC) stage (P < 0.01), indicating that PTEN expression was down‐regulated by advancement of the disease process. There were no statistically significant correlations between nuclear PTEN expression and the intensity and extent of cytoplasmic PTEN expression. The 10‐year overall survival rate was significantly better in patients with positive nuclear PTEN expression (n = 48 patients) compared with the rate in patients with negative nuclear PTEN expression (n = 49 patients; P < 0.01). The results of a multivariate analysis of factors that were prognostic for survival showed that AJCC stage (P < 0.05; relative risk, 2.038) and negative nuclear PTEN expression (P < 0.05; relative risk, 1.825) were significant factors indicative of poor survival.CONCLUSIONS: Nuclear PTEN expression may be a favorable biologic marker and a useful prognostic indicator in patients with esophageal squamous cell carcinoma. Cancer 2002;94:1955–60. © 2002 American Cancer Society.DOI 10.1002/cncr.10410Keywords
This publication has 22 references indexed in Scilit:
- PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinomaInternational Journal of Cancer, 2000
- Pten is essential for embryonic development and tumour suppressionNature Genetics, 1998
- Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell linesOncogene, 1998
- Allelic loss on chromosome 10q in human lung cancer: association with tumour progression and metastatic phenotypeBritish Journal of Cancer, 1998
- Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domainProceedings of the National Academy of Sciences, 1997
- Germline mutations in PTEN are present in Bannayan-Zonana syndromeNature Genetics, 1997
- Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndromeNature Genetics, 1997
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Allelotype study of esophageal carcinomaGenes, Chromosomes and Cancer, 1994